Research and development of drug delivery systems based on drug transporter and nano-formulation

Y Peng, L Chen, S Ye, Y Kang, J Liu, S Zeng… - Asian journal of …, 2020 - Elsevier
In recent years, the continuous occurrence of multi-drug resistance in the clinic has made
people pay more attention to the transporter. Changes in the expression and activity of …

[HTML][HTML] Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy

SK Gupta, P Singh, V Ali, M Verma - Oncology reviews, 2020 - ncbi.nlm.nih.gov
One of the major problems being faced by researchers and clinicians in leukemic treatment
is the development of multidrug resistance (MDR) which restrict the action of several tyrosine …

Organic cation transporters in the lung—current and emerging (patho) physiological and pharmacological concepts

MA Selo, JA Sake, C Ehrhardt, JJ Salomon - International Journal of …, 2020 - mdpi.com
Organic cation transporters (OCT) 1, 2 and 3 and novel organic cation transporters (OCTN) 1
and 2 of the solute carrier 22 (SLC22) family are involved in the cellular transport of …

Doxorubicin: An overview of the anti-cancer and chemoresistance mechanisms

I Micallef, B Baron - 2020 - um.edu.mt
Cancer remains one of the highest leading causes of morbidity and mortality worldwide.
Anthracyclines, specifically Doxorubicin (DOX), have been used for the past three decades …

Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway

XZ Liao, Y Gao, LL Sun, JH Liu, HR Chen… - Phytotherapy …, 2020 - Wiley Online Library
Cisplatin (DDP) is one of the first‐line chemotherapeutic agents for non‐small cell lung
cancer (NSCLC). However, repeated use of cisplatin in clinical practice often induces …

Physiological roles of ERM proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer

T Ogihara, K Mizoi, H Kamioka, K Yano - Cancers, 2020 - mdpi.com
Simple Summary Multidrug resistance and infiltration/metastasis of cancer are two major
issues that must be overcome during chemotherapy. Efflux transporters, such as P …

Germline variant burden in multidrug resistance transporters is a therapy‐specific predictor of survival in breast cancer patients

Q Xiao, Y Zhou, S Winter, F Büttner… - … Journal of Cancer, 2020 - Wiley Online Library
Multidrug resistance due to facilitated drug efflux mediated by ATP‐binding cassette (ABC)
transporters is a main cause for failure of cancer therapy. Genetic polymorphisms in ABC …

[HTML][HTML] Fluorescent probes for the dual investigation of MRP2 and OATP1B1 function and drug interactions

V Székely, I Patik, O Ungvári, Á Telbisz… - European Journal of …, 2020 - Elsevier
Detoxification in hepatocytes is a strictly controlled process, in which the governed action of
membrane transporters involved in the uptake and efflux of potentially dangerous molecules …

microRNA‐139‐5p confers sensitivity to antiepileptic drugs in refractory epilepsy by inhibition of MRP1

L Wang, L Song, X Chen, J Suo, Y Ma… - CNS Neuroscience …, 2020 - Wiley Online Library
Aim Drug resistance is an intractable issue urgently needed to be overcome for improving
efficiency of antiepileptic drugs in treating refractory epilepsy. microRNAs (miRNAs) have …

[HTML][HTML] Current insights toward kidney injury: Decrypting the dual role and mechanism involved of herbal drugs in inducing kidney injury and its treatment

TPS Laasya, S Thakur, R Poduri, G Joshi - Current Research in …, 2020 - Elsevier
The kidney is essential for the physiological functions of the body. When exposed to high
concentrations of toxins, these may induce the toxicity of the kidney (kidney injury), leading …